FAQs about the PDX project

  • Who can join the PDX consortium?

    We welcome contributors and collaborators to the PDX data consortium from PDX researchers, PDX vendors, non-profit organisations and academic communities.

  • Is participation in the PDX consortium free of charge?

    For the duration of the consortium, PDX vendors can list their name and descriptions of their data for free.

    PDX researchers who want to influence the development of the resource can sign up as consortium partners for a fee. Consortium partners are invited to participate in the consortium meetings and workshops and contribute feedback during the project.

    Signing up to our mailing list to be kept up-to-date on the project’s progress is free!

  • Will the PDX resource be free of charge?

    During the PDX platform pilot - the first 12 months - consortium partners will benefit from early access to the PDX platform and associated specialised services. Participating vendors will additionally have an opportunity to list their public data on the free public Repositive platform.

    After the public launch of the PDX platform, access to the PDX platform and premium services will be offered as a subscription service.

  • What are the benefits of the consortium for PDX users?

    The Repositive PDX resource will reduce redundancy and overhead in the PDX model selection workflow for pharmaceutical companies and other users. Essentially, the platform will accelerate research by streamlining the search process. Users will be able to find PDX models by searching through the portfolios of various vendors by metadata and molecular model characteristics. The search engine will have PDX-tailored functionality and present standardised data, thus promoting best practices for data quality and standards.

  • What are the benefits of the consortium for PDX vendors?

    The Repositive PDX resource will help vendors generate new leads and allow them to showcase their specialised expertise to potential customers. The resource may also help vendors manage their PDX model inventory and gather anonymised statistics and analytics. These stats will provide market insights to identify gaps in the market and gauge the popularity of different models. We are also working on functionality to track customer interactions and sales history to aid vendors who are not operating extensive CRM systems.

  • What are the milestones of the PDX project?

    The PDX project is currently in its 12-month pilot phase. We have been developing the PDX platform and gathering requirements and feedback from consortium partners. Participating PDX vendors are contributing descriptions and characterisations of their PDX models. Repositive is integrating these in the controlled environment on the PDX pilot platform.

    As the project plan develops, specific project milestones and progress will be shared with the consortium partners.

  • When will the PDX resource be available for users outside the consortium?

    We will announce a timeline for the public launch of the PDX platform at the end of the pilot project.

  • Who will own the rights to discoveries?

    The PDX resource allows users to select and compare PDX models from a range of providers based on molecular characteristics, without giving away the intellectual property of the providers. Individual users may decide to make an agreement with a provider to use their data for discovery research.

For any further information, please email info@repositive.io